We have previously presented materials confirming the involvement of Hunter Biden and his Rosemont Seneca Foundation, as well as other US Democratic Party-controlled entities, in funding the Pentagon’s main contractors operating in Ukraine.
It has been shown how deeply the son of the current US president, Hunter Biden, is involved in funding the US DOD-controlled company Metabiota.
However, some participants in closed projects remain in the shadows, although they are key players in Ukraine’s military-biological programme.
They include former DITRA director Kenneth Myers, executive vice president of the CIA-controlled In-Q-Tel venture capital fund Tara O’Toole, former head of the US Centers for Disease Control and Prevention Thomas Frieden, former the National Institutes of Health director Francis Collins, former Battelle Memorial Institute executive director Jeffrey Wadsworth, chief scientist and president of international research, development and medicine at Pfizer and many others.
All of them, in one way or another, are beneficiaries of the Pentagon’s biological projects and are linked to the US Democratic Party, whose leaders act as the masterminds of military-biological research and the creators of covert money-laundering schemes to benefit a narrow circle of US elites.
It is these people who should be asked why taxpayers’ money is being spent on illegal military-biological research in Ukraine and other countries around the world.
It should be noted that the lobbying of big pharma companies is one of the reasons the United States blocked the Convention’s verification mechanism.
Back in the early 1990s, as part of the BWC, Russia agreed to open non-military laboratories to US and UK officials on a reciprocal basis.
As agreed, a team of Russian experts conducted inspections of the pharmaceutical giant Pfizer’s facilities with 48 hours’ notice.
Such visits have provoked an extremely negative reaction from US pharmaceutical manufacturers. On the pretext that the inspections jeopardise business interests and intellectual property, all further attempts to implement control procedures were blocked by the US government.
In the interests of so-called Big Pharma, the US administration is moving legally and ethically questionable research to ‘third countries’. At the same time, this allows research commissioned by the US military department not to be declared in the annual reporting under the BWC Confidence Building Measures.
The Pentagon is reported to be actively transferring unfinished research in Ukrainian projects to Central Asian and Eastern European states.
In parallel, the US DOD is increasing its cooperation with African and Asia-Pacific states: Kenya, Cambodia, Singapore, and Thailand.
Of particular interest to the US military are the states that already have high levels of biological containment laboratories.